A French study comparing the excellence of research at biomedical research institutes in the United States and Europe has highlighted the symbiotic relationship between basic research and a thriving biotech industry.

Philippe Pouletty, president of France Biotech, presented results from a preliminary study into leading institutes at a conference organized by Fondation pour l'Innovation Politique in Paris last week (June 3).

For 27 different centers, he and colleagues calculated a "Life Sciences Excellence Index," based on the number of articles published in journals with an impact factor of more than 20, divided by the total number of papers, and expressed as a percentage.

"The goal is to have a simple objective index which can be looked at for various institutions independently of their size, overall output, structure, and so on," Pouletty told The Scientist.

By this measure, the top 10 institutes were: the Salk Institute (12.4%), the European...

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?